The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome.
Level 5 - mechanism / opinion, no new human data
Narrative review and hypothesis paper presenting mechanistic theory without primary trial data.
PubMed 39057678 · doi:10.3390/metabo14070355
What was done
The author synthesized mechanistic and observational literature to propose the "Cellular Stability Hypothesis" and define a putative nutritional condition termed "Cellular Fragility Syndrome." The paper reviews how pentadecanoic acid (C15:0) integrates into cell membranes, modulates mitochondrial function, and interacts with ferroptosis pathways across aging-associated cardiometabolic conditions.
What was found
The abstract reports theoretical and proposed threshold ranges rather than new primary experimental data: optimal long-term health and longevity are posited to require >0.4% to 0.64% C15:0 in cell membranes, whereas circulating levels ≤0.2% total fatty acids are defined as deficiency linked to ferroptosis, dysmetabolic iron overload syndrome, type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease.
Why it matters
This paper provides a unified conceptual framework linking odd-chain saturated fatty acid intake to cellular membrane integrity, ferroptosis resistance, and chronic disease prevention.
Limits
The abstract reflects a narrative review and hypothesis proposal rather than a systematic review or controlled human trial. No primary study sample size, experimental methodology, effect sizes, or statistical confidence intervals are provided in the abstract.
Cited by
- partial C15 (pentadecanoic acid) strengthens cells to support healthy aging.